The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
Pranav Pandya, head and mentor, All World Gayatri Pariwar, says he's not inclined to accept
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Minister of state for power Piyush Goyal will gift wooden-framed 'appreciation letters' to one million govt employees.
NHAI to pull plug on Rs 3,000-crore ventures for poor show
Lot will depend on the discom's ability to source cheap power and pass on the same to consumer
'In terms of growth rate, India is better than China.'
Sanjeev Vashishta, chief executive officer at SRL Diagnostics, talks to Deepak Patel about expansion plans and regulations for the sector.
Govt bans brands with annual sales worth Rs 3,728 crore.
Between 2011 and 2014, they indirectly determined the price of tyres in the market, says report
Lobby group tells USTR it has got assurance from India on compulsory licensing.
A dialysis machine contributes only 6 per cent to the overall cost.
11 states were assessed for access to clean water, energy and sanitation and use of iodised salt.
The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45.
The BSE fined 370 listed companies following the Sebi notification.
Sebi might come out with a regulatory framework for issuance of 'green' bonds
Ministry asks research body to take it to commercial level
The lowest bid earlier had come for Madhya Pradesh at Rs 5.05/unit.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances